Financhill
Buy
77

MIRM Quote, Financials, Valuation and Earnings

Last price:
$91.09
Seasonality move :
1.8%
Day range:
$90.86 - $93.70
52-week range:
$36.88 - $93.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
9.83x
P/B ratio:
16.02x
Volume:
336.1K
Avg. volume:
846.9K
1-year change:
98.67%
Market cap:
$4.7B
Revenue:
$336.9M
EPS (TTM):
-$0.86

Earnings Data

Next earnings date for MIRM
Feb 25
2026
Most recent earnings per share
$0.05
Beat by $0.21
(Nov 4/2025)
Consensus Estimate
-$0.16
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIRM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $146.7M -- -- -$0.02 --
02/25/2026 Q4 $140.2M -- -- -$0.04 --
11/04/2025 Q3 $130.5M $133M $0.05 -$0.16 $0.21
08/06/2025 Q2 $108.1M $127.8M -$0.12 -$0.33 $0.22
05/07/2025 Q1 $98.4M $111.6M -$0.30 -$0.27 -$0.03
02/26/2025 Q4 $96.6M $99.4M -$0.49 -$0.25 -$0.25
11/12/2024 Q3 $82M $90.4M -$0.30 -$0.45 $0.15
08/07/2024 Q2 $75.1M $77.9M -$0.52 -$0.46 -$0.06
05/08/2024 Q1 $70.2M $69.2M -$0.54 -$0.30 -$0.23
02/28/2024 Q4 $67.9M $69.6M -$0.71 -$0.22 -$0.48
11/02/2023 Q3 -- $47.7M -$0.57 -- --
08/03/2023 Q2 -- $37.5M -$1.94 -- --
05/04/2023 Q1 -- $31.6M -$0.80 -- --
03/08/2023 Q4 -- $27.9M -$0.99 -- --
11/09/2022 Q3 -- $18.8M -$1.02 -- --
08/04/2022 Q2 -- $17.5M -$0.84 -- --
05/05/2022 Q1 -- $12.9M -$1.17 -- --
03/09/2022 Q4 -- $3.1M $1.88 -- --
11/15/2021 Q3 -- $5M -$1.55 -- --
08/05/2021 Q2 -- $11M -$1.45 -- --
05/06/2021 Q1 -- -- -$1.68 -- --
03/09/2021 Q4 -- -- -$1.43 -- --
11/12/2020 Q3 -- -- -$0.86 -- --
08/06/2020 Q2 -- -- -$0.93 -- --
05/07/2020 Q1 -- -- -$0.86 -- --
03/12/2020 Q4 -- -- -$0.78 -- --
11/06/2019 Q3 -- -- -$0.66 -- --
08/28/2019 Q2 -- -- -$0.59 -- --
03/31/2019 Q1 -- -- -$0.26 -- --

Mirum Pharmaceuticals, Inc. Earnings Questions

  • How Much did Mirum Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Mirum Pharmaceuticals, Inc. reported $133M worth of top line sales in its most recent quarter.

  • Did Mirum Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Mirum Pharmaceuticals, Inc. announced earnings per share of $0.05 which represents a beat of analyst forecast a -$0.16 per share.

  • Is Mirum Pharmaceuticals, Inc. Profitable?

    Mirum Pharmaceuticals, Inc. reported $107.4M that represents $1.88 per share over the last quarter.

  • What is the Analyst Consensus for Mirum Pharmaceuticals, Inc. EPS Next Year?

    Mirum Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.85 per share to -$0.35 per share next year representing a decrease of -79.54%.

  • When is Mirum Pharmaceuticals, Inc.'s Earnings Date?

    Mirum Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Revolution Medicines a Good Stock to Own?
Is Revolution Medicines a Good Stock to Own?

Though it’s still quite early in the year, pharmaceutical startup…

Why Has Vistra Stock Gone Up?
Why Has Vistra Stock Gone Up?

Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…

Why Is Amkor Stock Up So Much?
Why Is Amkor Stock Up So Much?

Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
75
AGX alert for Jan 17

Argan, Inc. [AGX] is up 16.4% over the past day.

Buy
80
ASTS alert for Jan 17

AST Spacemobile, Inc. [ASTS] is up 14.32% over the past day.

Buy
84
IREN alert for Jan 17

IREN Ltd. [IREN] is up 11.35% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock